Video file

At its August 15, 2017 meeting, the Board approved more than $115 million to fund 20 comparative clinical effectiveness research (CER) studies on a range of conditions that impose high burdens on patients, their families and the healthcare system, and an additional $4 million to support four projects focused on improving methods for conducting CER. (More)